These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 11335788

  • 1. Increased sensitivity to cytosine arabinoside in human leukemia by c-raf-1 antisense oligonucleotides.
    Funato T, Kozawa K, Fujimaki S, Kaku M.
    Anticancer Drugs; 2001 Apr; 12(4):325-9. PubMed ID: 11335788
    [Abstract] [Full Text] [Related]

  • 2. In vitro leukemia cell models of Ara-C resistance.
    Funato T, Satou J, Nishiyama Y, Fujimaki S, Miura T, Kaku M, Sasaki T.
    Leuk Res; 2000 Jun; 24(6):535-41. PubMed ID: 10781689
    [Abstract] [Full Text] [Related]

  • 3. [Design of antisense oligodeoxynucleotide targeting at bcl-2 mRNA and observation on its effect on the sensitivity of leukemia cells to arabinosyl cytosine].
    Lei XY, Zhang Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):41-4. PubMed ID: 12667288
    [Abstract] [Full Text] [Related]

  • 4. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21CIP1 in leukemic cell (U937) differentiation induced by low concentrations of 1-beta-D-arabinofuranosylcytosine.
    Wang Z, Wang S, Fisher PB, Dent P, Grant S.
    Differentiation; 2000 Aug; 66(1):1-13. PubMed ID: 10997587
    [Abstract] [Full Text] [Related]

  • 5. Susceptibility to cytosine arabinoside (Ara-C)-induced cytotoxicity in human leukemia cell lines.
    Kanno S, Higurashi A, Watanabe Y, Shouji A, Asou K, Ishikawa M.
    Toxicol Lett; 2004 Sep 10; 152(2):149-58. PubMed ID: 15302096
    [Abstract] [Full Text] [Related]

  • 6. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
    Wang Z, Van Tuyle G, Conrad D, Fisher PB, Dent P, Grant S.
    Cancer Res; 1999 Mar 15; 59(6):1259-67. PubMed ID: 10096557
    [Abstract] [Full Text] [Related]

  • 7. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S, Mukherjee SK, Taylor BJ, Ivy SP, Fu CH, Ardi VC, Avramis VI.
    Anticancer Res; 2000 Mar 15; 20(1A):139-50. PubMed ID: 10769646
    [Abstract] [Full Text] [Related]

  • 8. Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein.
    Fu CH, Martin-Aragon S, Weinberg KI, Ardi VC, Danenberg PV, Avramis VI.
    Cancer Chemother Pharmacol; 2001 Aug 15; 48(2):123-33. PubMed ID: 11561778
    [Abstract] [Full Text] [Related]

  • 9. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.
    Ramilo-Torno LV, Avramis VI.
    Cancer Chemother Pharmacol; 1995 Aug 15; 35(3):191-9. PubMed ID: 7805176
    [Abstract] [Full Text] [Related]

  • 10. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J, Jarvis WD.
    Cell Growth Differ; 1996 May 15; 7(5):603-13. PubMed ID: 8732670
    [Abstract] [Full Text] [Related]

  • 11. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
    Avramis IA, Laug WE, Sausville EA, Avramis VI.
    Cancer Chemother Pharmacol; 2003 Oct 15; 52(4):307-18. PubMed ID: 12827297
    [Abstract] [Full Text] [Related]

  • 12. c-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells.
    Dong J, Naito M, Tsuruo T.
    Oncogene; 1997 Aug 07; 15(6):639-47. PubMed ID: 9264404
    [Abstract] [Full Text] [Related]

  • 13. [Bcl-2 antisense oligodeoxynucleotide enhances araninosyl cytosine-induced apoptosis of primary leukemia cells].
    Lei XY, Zhang H, He DM.
    Ai Zheng; 2002 Dec 07; 21(12):1301-4. PubMed ID: 12520735
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxicity of etoposide in cancer cell lines in vitro after BCL-2 and C-RAF gene silencing with antisense oligonucleotides.
    Sypniewski D, Bednarek I, Gałka S, Loch T, Błaszczyk D, Sołtysik D.
    Acta Pol Pharm; 2013 Dec 07; 70(1):87-97. PubMed ID: 23610963
    [Abstract] [Full Text] [Related]

  • 15. Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer.
    McPhillips F, Mullen P, Monia BP, Ritchie AA, Dorr FA, Smyth JF, Langdon SP.
    Br J Cancer; 2001 Nov 30; 85(11):1753-8. PubMed ID: 11742498
    [Abstract] [Full Text] [Related]

  • 16. In BCR-ABL-positive cells, STAT-5 tyrosine-phosphorylation integrates signals induced by imatinib mesylate and Ara-C.
    Kindler T, Breitenbuecher F, Kasper S, Stevens T, Carius B, Gschaidmeier H, Huber C, Fischer T.
    Leukemia; 2003 Jun 30; 17(6):999-1009. PubMed ID: 12764361
    [Abstract] [Full Text] [Related]

  • 17. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S, Bullock G, Nuñez G, Tang C, Ibrado AM, Huang Y, Bhalla K.
    Cell Growth Differ; 1996 Dec 30; 7(12):1617-23. PubMed ID: 8959329
    [Abstract] [Full Text] [Related]

  • 18. Induction of cytosine arabinoside-resistant human myeloid leukemia cell death through autophagy regulation by hydroxychloroquine.
    Kim Y, Eom JI, Jeung HK, Jang JE, Kim JS, Cheong JW, Kim YS, Min YH.
    Biomed Pharmacother; 2015 Jul 30; 73():87-96. PubMed ID: 26211587
    [Abstract] [Full Text] [Related]

  • 19. Interaction of cytosine arabinoside and lovastatin in human leukemia cells.
    Holstein SA, Hohl RJ.
    Leuk Res; 2001 Aug 30; 25(8):651-60. PubMed ID: 11397469
    [Abstract] [Full Text] [Related]

  • 20. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines.
    Muszynski KW, Ruscetti FW, Gooya JM, Linnekin DM, Keller JR.
    Stem Cells; 1997 Aug 30; 15(1):63-72. PubMed ID: 9007224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.